Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Phase 3

Completed

• Conditions: Ocular Hypertension

• Registration Number: NCT00332436
• Lead Sponsor: Allergan

Brief Summary

The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension

Detailed Description

Not available

Study Timeline

• Study Start: 1999-12
• Primary Completion: 2001-11
• Study Completion: 2001-11
• Study First Submitted: 2006-05-30
• Study First Submitted QC: 2006-05-30
• Study First Posted: 2006-06-01
• Status Verified: 2011-05
• Last Update Submitted: 2011-05-27
• Last Update Posted: 2011-05-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 586

Inclusion Criteria

• Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes
• Patient requires IOP-lowering drug in both eyes

Exclusion Criteria

• Uncontrolled medical condition
• Contraindication to beta-adrenoceptor antagonist or brimonidine therapy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
IOP